Please assess the completion status of the following clinical trial:

Trial Title: Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* laparoscopic cholecystectomy or gynecological laparoscopic surgery~* ASA I or II~* adult patient~* body mass index between 17 and 33 kg/m2~Exclusion Criteria:~* pregnancy~* arrhythmia~* pace maker~* diabetes mellitus~* dysautonomia~* treatment with beta blocking agents

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ANI guided remifentanil arm (Type: EXPERIMENTAL): remifentanil targets are increased or decreased depending on ANI readings. In case of high blood pressure associated with elevated ANI, nicardipine is administered.
- ANI blind arm (Type: OTHER): remifentanil target is adapted as is usual during general anesthesia, depending on hemodynamic reactions to nociceptive surgical stimulations. In case of elevated blood pressure despite a maximum target of 10 ng/ml (Minto Pk/pD model), then nicardipine is administered.

Based on this trial design, predict the completion outcome and termination type (if applicable).